Rhematoid Arthritis_CME symposium program abstracts and introduction written by Crystal Kaczkowski

This document discusses emerging therapies for rheumatoid arthritis (RA), particularly focusing on selective T cell co-stimulation modulators like abatacept, which have shown efficacy and safety in clinical trials. It highlights the need for new treatment options due to inadequate responses and side effects from current therapies. The symposium aims to educate rheumatologists on the immunological basis of RA and the latest advancements in its management.